Clinical Trials
26 trialsNatural History Study of Patients With Neurofibromatosis Type I
National Institutes of Health Clinical Center (CC)
Genetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility Genes
National Institutes of Health Clinical Center (CC)
Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma
Fox Chase Cancer Center
Long-Term Longitudinal QoL in Patients Undergoing EEA
Ohio State University
OvAR-Y
Washington University School of Medicine
the Exploration of MTAP Deletion in Osteosarcoma by Immunohistochemistry
Peking University People's Hospital
Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study
M.D. Anderson Cancer Center
RIPAF
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Genetic Mutational Analysis of Saliva or Buccal Mucosa Samples From Patients With Embryonal or Alveolar Rhabdomyosarcoma
Children's Oncology Group
KS-CARE
UNC Lineberger Comprehensive Cancer Center
Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis
National Institutes of Health Clinical Center (CC)
GIST
National Health Research Institutes, Taiwan
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
Memorial Sloan Kettering Cancer Center
Electrochemotherapy in Musculoskeletal Tumors
Istituto Ortopedico Rizzoli
Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1
Johns Hopkins University
Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group
Children's Oncology Group
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
TScan Therapeutics, Inc.
Genomic Structural Variation in Cancer Susceptibility
Memorial Sloan Kettering Cancer Center
INSPECTOR
Istituto Ortopedico Rizzoli
Pediatric Oncological Orthopaedic Reconstruction
Istituto Ortopedico Rizzoli
The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determination
Peking University People's Hospital
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment
Peking University People's Hospital
Selinexor
Durham VA Medical Center
POSS
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Biomechanics of Metastatic Defects in Bone
Beth Israel Deaconess Medical Center